Dr. Peter S. Tippett, founder and CEO of careMESH, a healthcare communication platform that enables hospitals and clinicians to securely share patient data with any other U.S. healthcare provider discusses how healthcare interoperability has changed over the years and how COVID accelerated the need for better patient-to-physician transfer of care.
Dr. Peter S. Tippett is currently CEO of careMESH. He is a physician, scientist, business leader and technology entrepreneur with extensive risk management and health information technology expertise. One of his early startups created the first commercial antivirus product, Certus (which sold to Symantec and became Norton Antivirus). As a leader in the global information security industry (ICSA Labs, TruSecure, CyberTrust, Information Security Magazine), Tippett developed a range of foundational and widely accepted risk equations and models. He was a member of the President’s Information Technology Advisory Committee (PITAC) under G.W. Bush, and served with both the Clinton Health Matters and NIH Precision Medicine initiatives. Throughout his career, Tippett has been recognized with numerous awards and recognitions — including E&Y Entrepreneur of the Year, the U.S. Chamber of Commerce “Leadership in Health Care Award”, and was named one of the 25 most influential CTOs by InfoWorld.Tippett is board certified in internal medicine and has decades of experience in the ER. As a scientist, he created the first synthetic immunoglobulin in the lab of Nobel Laureate Bruce Merrifield at Rockefeller University. His PhD in Biochemistry (Case Western Reserve University) included among the first computer modeling of biologic processes. He also holds a B.S. in Biology from Kalamazoo College.